Company · Montreal, Quebec, Canada
Juno Pharma Canada Inc.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 44
- 43 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 24
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ARGATROBAN FOR INJECTIONStatus since Jan 2026 | 02561557 | Marketed | |
| BIMATOPROST RCStatus since Mar 2026 | 02529580 | Marketed | |
| CALCIUM CHLORIDE INJECTION USPStatus since Jun 2026 | 00821780 | Marketed | |
| CARBETOCIN INJECTIONStatus since Jul 2026 | 02489244 | Marketed | |
| CARBOPROST TROMETHAMINE INJECTION USPStatus since Jun 2026 | 02538377 | Marketed | |
| CASPOFUNGIN FOR INJECTIONStatus since Apr 2026 | 02460947 | Marketed | |
| CASPOFUNGIN FOR INJECTIONStatus since Apr 2026 | 02460955 | Marketed | |
| CISATRACURIUM BESYLATE INJECTION USP MULTIDOSEStatus since Oct 2026 | 02408813 | Marketed | |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USPStatus since Feb 2026 | 02467976 | Marketed | |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTIONStatus since Feb 2026 | 02487365 | Marketed | |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTIONStatus since Feb 2026 | 02487373 | Marketed | |
| DEXRAZOXANE FOR INJECTIONStatus since Jul 2026 | 02544083 | Marketed | |
| EPTIFIBATIDE INJECTIONStatus since May 2026 | 02540819 | Marketed | |
| EPTIFIBATIDE INJECTIONStatus since May 2026 | 02540827 | Marketed | |
| ERTAPENEM FOR INJECTIONStatus since Jun 2026 | 02490773 | Marketed | |
| HALOPERIDOL INJECTIONStatus since Aug 2026 | 02366010 | Marketed | |
| IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTIONStatus since Aug 2026 | 02483394 | Marketed | |
| KETOROLAC TROMETHAMINE INJECTION, USPStatus since Aug 2026 | 02443376 | Marketed | |
| LIDOCAINE HYDROCHLORIDE INJECTIONStatus since May 2026 | 02542196 | Marketed | |
| LIDOCAINE HYDROCHLORIDE INJECTIONStatus since May 2026 | 02542218 | Marketed | |
| METOPROLOL TARTRATE INJECTION USPStatus since May 2026 | 02474271 | Marketed | |
| MICAFUNGIN SODIUM FOR INJECTIONStatus since Jul 2026 | 02547228 | Marketed | |
| MICAFUNGIN SODIUM FOR INJECTIONStatus since Jul 2026 | 02547236 | Marketed | |
| NITROJECTStatus since Oct 2025 | 00778869 | Marketed | |
| NOROMBYStatus since May 2026 | 02506459 | Marketed | |
| NOROMBYStatus since May 2026 | 02506467 | Marketed | |
| NOROMBYStatus since May 2026 | 02506475 | Marketed | |
| NOROMBYStatus since May 2026 | 02506483 | Marketed | |
| NOROMBYStatus since May 2026 | 02506491 | Marketed | |
| NOROMBY HPStatus since May 2026 | 02506505 | Marketed | |
| NOROMBY HPStatus since May 2026 | 02506513 | Marketed | |
| POTASSIUM ACETATE INJECTION USPStatus since Oct 2025 | 02362597 | Marketed | |
| ROCURONIUM BROMIDE INJECTIONStatus since May 2026 | 02469774 | Marketed | |
| SCOPOLAMINE HYDROBROMIDE INJECTIONStatus since Jun 2026 | 02242810 | Marketed | |
| SCOPOLAMINE HYDROBROMIDE INJECTIONStatus since Jun 2026 | 02242811 | Marketed | |
| SUGAMMADEX INJECTIONStatus since Feb 2026 | 02539144 | Marketed | |
| CISATRACURIUM SINGLE DOSEStatus since Oct 2026 | 02408805 | Dormant | |
| LEVOCARNITINE INJECTIONStatus since Mar 2026 | 02566958 | Approved | |
| MORPHINE SULFATE INJECTIONStatus since Sep 2025 | 02561212 | Approved | |
| MORPHINE SULFATE INJECTIONStatus since Sep 2025 | 02561220 | Approved | |
| NOROMBYStatus since May 2026 | 02506440 | Approved | |
| PHENYTOIN SODIUM INJECTION USPStatus since Jul 2026 | 00498335 | Dormant | |
| ZOLEDRONIC ACID INJECTIONStatus since Jan 2026 | 02564696 | Approved | |
| DEXRAZOXANE FOR INJECTIONStatus since Jul 2026 | 02544091 | Cancelled Pre Market |
Notices of Compliance
Newest first.
- LABETALOL HYDROCHLORIDE INJECTIONOctober 9, 2026 · NOC 38435 · Abbreviated New Drug Submission (ANDS)
- NALOXONE HYDROCHLORIDE INJECTIONOctober 9, 2026 · NOC 38439 · Abbreviated New Drug Submission (ANDS)
- CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE; CISATRACURIUM SINGLE DOSEOctober 6, 2026 · NOC 38417 · Abbreviated New Drug Submission (ANDS)
- KETOROLAC TROMETHAMINE INJECTION, USPAugust 28, 2026 · NOC 38194 · Abbreviated New Drug Submission (ANDS)
- IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTIONAugust 28, 2026 · NOC 38196 · Abbreviated New Drug Submission (ANDS)
- HALOPERIDOL INJECTIONAugust 20, 2026 · NOC 38146 · Abbreviated New Drug Submission (ANDS)
- MICAFUNGIN SODIUM FOR INJECTIONJuly 27, 2026 · NOC 38010 · Abbreviated New Drug Submission (ANDS)
- CARBETOCIN INJECTIONJuly 8, 2026 · NOC 37858 · Abbreviated New Drug Submission (ANDS)
- DEXRAZOXANE FOR INJECTIONJuly 6, 2026 · NOC 37850 · Abbreviated New Drug Submission (ANDS)
- CARBOPROST TROMETHAMINE INJECTION USPJune 30, 2026 · NOC 37808 · Abbreviated New Drug Submission (ANDS)
- ERTAPENEM FOR INJECTIONJune 2, 2026 · NOC 37638 · Abbreviated New Drug Submission (ANDS)
- EPTIFIBATIDE INJECTIONMay 29, 2026 · NOC 37629 · Abbreviated New Drug Submission (ANDS)
- NOROMBY; NOROMBY HPMay 28, 2026 · NOC 37624 · New Drug Submission (NDS)
- SUGAMMADEX INJECTIONMay 22, 2026 · NOC 37590 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METOPROLOL TARTRATE INJECTION USPMay 14, 2026 · NOC 37555 · Abbreviated New Drug Submission (ANDS)
- ROCURONIUM BROMIDE INJECTIONMay 5, 2026 · NOC 37497 · Abbreviated New Drug Submission (ANDS)
- CASPOFUNGIN FOR INJECTIONApril 27, 2026 · NOC 37404 · Abbreviated New Drug Submission (ANDS)
- LEVOCARNITINE INJECTIONMarch 25, 2026 · NOC 37173 · Abbreviated New Drug Submission (ANDS)
- BIMATOPROST RCMarch 16, 2026 · NOC 37106 · Abbreviated New Drug Submission (ANDS)
- SUGAMMADEX INJECTIONFebruary 24, 2026 · NOC 36963 · Abbreviated New Drug Submission (ANDS)
- DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP; DEXMEDETOMIDINE HYDROCHLORIDE INJECTIONFebruary 20, 2026 · NOC 36936 · Abbreviated New Drug Submission (ANDS)
- ZOLEDRONIC ACID INJECTIONJanuary 19, 2026 · NOC 36746 · Abbreviated New Drug Submission (ANDS)
- NITROJECTOctober 17, 2025 · NOC 36200 · New Drug Submission (NDS)
- ARGATROBAN FOR INJECTIONOctober 2, 2025 · NOC 36100 · Abbreviated New Drug Submission (ANDS)